[Juvenile dermatomyositis, systemic lupus erythematosus and mixed connective tissue disease]

[Juvenile dermatomyositis, systemic lupus erythematosus and mixed connective tissue disease] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Juvenile dermatomyositis, systemic lupus erythematosus and mixed connective tissue disease] Abstract Text:

I Hiemstra,E A Sanders,H A Tiddens,

This paper covers the current insights into the classification, etiology, management and prognosis of juvenile dermatomyositis (JDMS) systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD). Since specific diagnostic tests for these autoimmune diseases are not available, diagnosis depends on the presence of defined criteria. Drug therapy in JDMS consists of prednisone at a low dosage (1 mg/kg/day). In SLE different therapeutic approaches are known depending on the occurrence of life threatening symptoms. The prognosis of MCTD is good, it is of prime importance to avoid overdosage of corticosteroids, since drug treatment is often not needed.

[Juvenile dermatomyositis, systemic lupus erythematosus and mixed connective tissue disease] Publishing Authors By Initials

I Hiemstra,EA Sanders,HA Tiddens,

For similar diagnosis: prognosis research abstracts see: diagnosis: prognosis research

PUBMED ID PMID:

MEDLINE DATE:

[Juvenile dermatomyositis, systemic lupus erythematosus and mixed connective tissue disease] Journal Published:

PUBLICATION TYPE: Review

Journal: Tijdschrift voor kindergeneeskunde

VOLUME: 59

Page Numbers: 185-9

Journal Abbreviation: Tijdschr Kindergeneeskd

ISSN: 0376-7442

DAY: 24

MONTH: Oct

YEAR: 1991

[Juvenile dermatomyositis, systemic lupus erythematosus and mixed connective tissue disease] Information

Number of References: 19

LANGUAGE: dut

NlmUniqueID: 7704039

[Juvenile dermatomyositis, systemic lupus erythematosus and mixed connective tissue disease] Keywords Mesh Terms:

KEYWORDS: Prognosis

MESH TERMS: drug therapy

Chemical & Substance for Abstract: [Juvenile dermatomyositis, systemic lupus erythematosus and mixed connective tissue disease] Information

Substance Name: Antineoplastic Agents

Registry Number: 0

Grant and Affiliation Information for [Juvenile dermatomyositis, systemic lupus erythematosus and mixed connective tissue disease]

AFFILIATION: Afd. Immunologie en Reumatologie, Universiteitskliniek voor kinderen en jeugdigen, Het Wilhelmina Kinderziekenhuis, Utrecht.

Country: NETHERLANDS

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Tijdschr Kindergeneeskd

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Juvenile dermatomyositis, systemic lupus erythematosus and mixed connective tissue disease Related Publications

• Aerosol delivery to young children by pMDI-spacer: is facemask design important?
• Authors' reply.
• Inhaled antibiotics.
• Matching the device to the patient.
• Recombinant human DNase nebulisation in children with cystic fibrosis: before bedtime or after waking up?
• [Juvenile dermatomyositis, systemic lupus erythematosus and mixed connective tissue disease]